Health Catalyst (HCAT)
(Delayed Data from NSDQ)
$6.03 USD
+0.43 (7.68%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $6.02 -0.01 (-0.17%) 5:32 PM ET
2-Buy of 5 2
C Value D Growth B Momentum C VGM
Income Statements
Fiscal Year end for Health Catalyst, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 296 | 276 | 242 | 189 | 155 |
Cost Of Goods | 164 | 143 | 124 | 98 | 75 |
Gross Profit | 132 | 133 | 118 | 91 | 80 |
Selling & Adminstrative & Depr. & Amort Expenses | 259 | 273 | 261 | 187 | 134 |
Income After Depreciation & Amortization | -127 | -140 | -144 | -96 | -55 |
Non-Operating Income | 0 | 0 | 0 | -9 | -2 |
Interest Expense | -9 | 2 | 16 | 12 | 3 |
Pretax Income | -118 | -142 | -160 | -116 | -60 |
Income Taxes | 0 | -4 | -7 | -1 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -118 | -137 | -153 | -115 | -60 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -118 | -137 | -153 | -115 | -60 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -83 | -90 | -94 | -69 | -45 |
Depreciation & Amortization (Cash Flow) | 44 | 50 | 49 | 27 | 10 |
Income After Depreciation & Amortization | -127 | -140 | -144 | -96 | -55 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 56.42 | 54.08 | 47.50 | 39.54 | 18.74 |
Diluted EPS Before Non-Recurring Items | -0.84 | -1.59 | -1.82 | -1.64 | -1.42 |
Diluted Net EPS (GAAP) | -2.09 | -2.63 | -3.23 | -2.91 | -12.86 |
Fiscal Year end for Health Catalyst, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 75.08 | 73.77 | 73.21 | 73.87 |
Cost Of Goods | NA | 44.58 | 41.79 | 39.44 | 38.30 |
Gross Profit | NA | 30.51 | 31.99 | 33.78 | 35.56 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 63.29 | 56.57 | 68.40 | 70.47 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -32.78 | -24.58 | -34.62 | -34.91 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | -2.62 | -2.61 | -2.09 | -1.79 |
Pretax Income | NA | -30.17 | -21.97 | -32.53 | -33.12 |
Income Taxes | NA | 0.14 | 0.06 | 0.09 | 0.07 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -30.31 | -22.03 | -32.61 | -33.19 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -30.31 | -22.03 | -32.61 | -33.19 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 57.48 | 56.71 | 55.98 | 55.49 |
Diluted EPS Before Non-Recurring Items | NA | -0.21 | -0.22 | -0.21 | -0.20 |
Diluted Net EPS (GAAP) | NA | -0.52 | -0.39 | -0.58 | -0.60 |